LifeMD (NASDAQ:LFMD) Upgraded by Zacks Investment Research to Hold

LifeMD} stock has undergone multiple analysts rating changes in the recent past.  LifeMD Upgraded by Zacks Investment Research on 10/28/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More LifeMD (NASDAQ:LFMD) Upgraded by Zacks Investment Research to Hold